CardioTech to Showcase its Innovative Technology at MD&M West Expo on January 29-31

Date : 01/22/2008 @ 10:51AM
Source : PR Newswire
Stock : Cardiotech International, (CTE)
Quote : 0.64  0.06 (10.34%) @ 2:21PM
<< BackQuote Chart Financials

 



CardioTech to Showcase its Innovative Technology at MD&M West Expo on January 29-31

WILMINGTON, Mass., Jan. 22 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (AMEX:CTE), a developer and manufacturer of advanced materials and medical devices for the treatment of a broad range of disease states, today announced that it will be showcasing its innovative technology at the world's largest medical OEM event -- Medical Design & Manufacturing (MD&M West) -- that will take place January 29 - 31 at the Anaheim Convention Center in California. Dr. Andrew Reed, CardioTech's Vice President of Science and Technology, and Phil Beck, Vice President and General Manager of the Company's Contract Manufacturing division CDT, will be heading the exposition team at Booth # 2422.

"MD&M West provides a perfect opportunity to discuss our approach to customizing proprietary polymers for specific customer applications in a wide range of device categories. CardioTech's mission is to inform new and existing customers about the enhancements to their medical devices that CardioTech's performance polymers can deliver," Dr. Reed noted.

MD&M West Conference & Exposition

Providing an unparalleled array of resources for the design and manufacture of both current and next-generation medical devices, MD&M West delivers the most complete and comprehensive resource for medical manufacturers.

About CardioTech International:

CardioTech is a developer of advanced polymer materials and manufacturer of medical products for the treatment and diagnosis of a broad range of disease states. The Company's business model leverages its proprietary materials science technology and manufacturing expertise in order to expand its product sales and royalty and development fee income. It develops next generation polymers and manufactures new and complex medical devices to customers' unique specifications. CardioTech is conducting its first clinical trial for regulatory approval in Europe for its CardioPass synthetic coronary bypass graft. More information about CardioTech is available at its website: http://www.cardiotech-inc.com/

For Further Information Contact: Eric Walters Vice President & Chief Financial Officer CardioTech International, Inc.

978-657-0075

Sylvia Dresner Senior Vice President VMW Corporate & Investor Relations 212-616-6161

http://www.newscom.com/cgi-bin/prnh/20070322/CLTH022LOGO

http://photoarchive.ap.org/

DATASOURCE: CardioTech International, Inc.

CONTACT: Eric Walters, Vice President & Chief Financial Officer of

CardioTech International, Inc., +1-978-657-0075,

; or Sylvia Dresner, Senior Vice President of

VMW Corporate & Investor Relations, +1-212-616-6161,

Web site: http://www.cardiotech-inc.com/

<< Back


Cardiotech International, Historical Chart Cardiotech International, Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
40 site:2us 080724 15:08 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )